The BMJ Rapid Recs team notes that pts who place more value on avoiding complications from bx and CA tx are likely to decline screening In contrast pts who put more value in even a small reduction of prostate CA mortality i e those at high baseline risk b

The BMJ Rapid Recs team notes that pts who place more value on avoiding complications from bx and CA tx are likely to decline screening. In contrast, pts who put more value in even a small reduction of prostate CA mortality (i.e., those at high baseline risk because of FHx or African descent, or who want to r/o dx) may opt for screening.⁷